Exopharm Ltd (EX1)
20mins delayed
Movement
1 Year Return
Exopharm Ltd Chart
| Share price | |
| Last | |
| Change | |
| Volume | |
| Turnover | |
| Market Cap | $19.14 million |
| Today's Movement | |
| Prev. Close | |
| Open | |
| Day Range | - |
| VWAP | |
| Historical Stats | |
| 52w Range | - |
| 4w Avg Volume | |
| 4w Avg Turnover | |
| (delayed) | |
EX1 Statistics
15 July
1,493 / 2,232
ASX Size Rank
1yr Return
vs Sector (1yr)
-48.49%
vs ASX 200 (1yr)
-17.58%
$19.14 million
Market Cap
Share Issue
59.81 million
All Ords (%)
N/A
Short Sold
0%
Current Fundamentals
15 July
N/A
PE Ratio
EPS ($)
-0.062
Earnings Yield
-19.28%
NTA ($)
0.07
N/A
Dividend Yield
DPS ($)
-
Gross Div. Yield
-
Gross DPS ($)
-
Company Overview
Exopharm Limited (EX1) is an Australian biopharmaceutical company that deals in developing regenerative medicine, primarily being the development and de-risking of exosome technologies, particularly the LEAP manufacturing process and development of the PlexarisTM and ExomereTM products.
Upcoming Calendar
Dividend History
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| No dividends paid in the last 5 years | ||||
See Upcoming Dividends for all ASX companies.
Announcements
| Date | Heading | Pages | File Size | Time |
|---|---|---|---|---|
Broker Consensus
The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.
EX1 is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.
Directors & Management
| Name | Title | Since | Bio |
|---|---|---|---|
| Mr David Rodney Parker | Non-Executive Director | Jun 2018 |
|
| Dr Ian Edward Dixon | Company Founder, Technology Co-Founder, Managing Director | May 2013 |
|
| Mr Jason Mark Watson | Non-Executive Chairman, Non-Executive Director | Aug 2018 |
|
Director Transactions
EX1 directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
| Date | Director | Type | Amount | Price | Value | Notes |
|---|---|---|---|---|---|---|
| 13/09/19 | Jason Watson | Issued | 100,000 | $0.370 | $37,000 | Placement. |
| 19/08/19 | David Parker | Buy | +20,000 | $0.370 | $7,400 | Participation in share purchase plan. |
| 19/08/19 | Ian Dixon | Buy | +40,000 | $0.370 | $14,800 | Participation in share purchase plan. |
| 19/08/19 | Jason Watson | Buy | +40,000 | $0.370 | $14,800 | Participation in share purchase plan. |
Shareholder Distribution
| Holding Size | 1 - 1,000 | 1,001 - 5,000 | 5,001 - 10,000 | 10,001 - 100,000 | 100,001 and over | Total Shareholders |
|---|---|---|---|---|---|---|
| No. of Shareholders | 21 | 80 | 125 | 549 | 166 | 941 |
Top 20 Shareholders
| Name | Shares | Capital |
|---|---|---|
| Altnia Holdings Pty Ltd (Dixon Family A/C) | 27,975,294 | 29.33% |
| Mr Michael Francis Mcmahon & Mrs Susan Lesley Mcmahon (Mcmahon Super Fund A/C) | 2,310,000 | 2.42% |
| Oldview Enterprises Pty Ltd (The Priestley A/C) | 1,476,963 | 1.55% |
| Anthony John Locantro | 1,330,000 | 1.39% |
| Carda Pty Ltd (Carda Super Fund A/C) | 1,220,000 | 1.28% |
| Phytose Corporation Pty Limited (Boundaryone Super A/C) | 1,176,471 | 1.23% |
| Pabasa Pty Ltd (Kehoe Family Super Fund A/C) | 1,000,000 | 1.05% |
| Mrs Anna Felicia Belton | 978,334 | 1.03% |
| Acns Capital Markets Pty Ltd | 810,000 | 0.85% |
| Drp 2006 Super Pty Ltd (Drp (2006) Super Fund A/C) | 760,000 | 0.80% |
| Basapa Pty Ltd (Kehoe Family A/C) | 750,000 | 0.79% |
| Kohen Enterprises Pty Ltd | 750,000 | 0.79% |
| Lonhro (Wa) Pty Ltd (Lonhro A/C) | 736,667 | 0.74% |
| Saintly Company Pty Ltd (Walker Investment A/C) | 670,000 | 0.70% |
| Mr Andrew Stewart Coles & Ms Alexandra Constance Manook (Coles Family Super A/C) | 615,000 | 0.64% |
| Gregor Lichtfuss | 588,235 | 0.62% |
| Mr Anthony De Nicola & Mrs Tanya Louise De Nicola (De Nicola Family S/F A/C) | 575,000 | 0.60% |
| Jeccs Pty Ltd (Brown Family No1 A/C) | 547,000 | 0.57% |
| Labonne Enterprises Pty Ltd (Mcintyre Family A/C) | 500,000 | 0.52% |
| Ringsford Pty Ltd (Dg & Gl Walker S/F A/C) | 500,000 | 0.52% |
| All other shareholders | 52.58 % | |
The Top 20 Shareholders of EX1 hold 47.42% of shares on issue.
EX1 Share Price History
| Date | Close | Change | % Change | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
EX1 Historical Data
Download up to 20 years of share price history.
| Year | Closing Price (30 June) | Last Trade |
|---|---|---|
| 2019 | $0.41 | 28 June |
Offical data as published by ASX. See more Data Downloads.
Company Details
Principal Activity: Developing regenerative medicine, primarily being the development and de-risking of exosome technologies, particularly the LEAP manufacturing process and development of the Plexaris and Exomere products.
Incorporated: --
Level 17, 31 Queen St
Melbourne VIC 3000
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.